SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo

NEW YORK,Feb. 14,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

HONG KONG,Feb. 14,2025-- On 12 February 2025,S&P Global released the Sustainability Yearbook 2025.Fosun International Limited (HKEX Stock Code: 00656,"Fosun International") was successfu

New customers enjoy 3.0%*p.a. on SGD BusinessGo / BusinessGo-i Account and 3.8%* p.a. on USD Interest Plus Current Account / USD BusinessGo-i Account

SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali

HONG KONG,Feb. 14,2025-- For the first time,the prestigious five-star international equestrian event with over 50 years of history in London has chosen Hong Kong as its venue,heralding the fruitful Ye

XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr

CULVER CITY,Calif.,Feb. 14,2025-- Snail Games (Nasdaq: SNAL),a premier global developer and publisher of interactive digital entertainment,celebrates new milestones that are reshaping the ARK universe

XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).

- The company reports KRW373.0 billion in net sales,KRW166.3 billion in operating profit,and KRW142.4 billion in net income,reflecting year-over-year increases of 16.7%,41.2%,and 45.8%,respectively